Health

Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?

TribeNews
By TribeNews Add a Comment 3 Views
0 Min Read
Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?

MedPage Today) — A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app